CH14.18 1021 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CH14.18 1021 antibody, covering 2023-12-08 to 2023-12-08. Get the full timeline:
Most recent: Clinical Trial Update: CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma [Phase 2]